The pharmaceutical industry is sometimes described as crisis-proof — its demand tends to self-regulate regardless of world economic and political events. Pharma is a cornerstone of the regional economy in Bristol and has historically maintained steady growth. Bristol is the third-largest life sciences sector in the United Kingdom and hosts nearly 200 independent life science companies. Here are the top Bristol pharmaceutical companies to know.
Pharmaceutical Companies in Bristol
- FluoretiQ
- Amcor
- eXmoor pharma
- Bio-Techne
- IQVIA
Top Pharmaceutical Companies in Bristol
eXmoor pharma is a CDMO, or contract development and manufacturing organization, in the pharmaceutical sector. Its technology uses cells and genes to develop biopharmaceutical products on a third-party basis, working in collaboration with clients to turn their discovery technology into marketable pharmaceutical products.
IQVIA is a consultancy that serves businesses in the pharmaceutical and biotech industries. It offers technology, analytics and research operations expertise. IQVIA’s client base is made up of companies working on healthcare products, which range from digital therapeutics to prescription drugs. IQVIA specializes in supporting Phase I-IV clinical trials and in big data applications for healthcare.
FluoretiQ is a pharmaceutical startup that works with bacterial diagnostic technology to develop point-of-care diagnostic products. When bacteria can be precisely identified, they can be accurately targeted by antibiotics, sparing both the individual patient and the collective environment from the burden of high-scale use of broad-spectrum antibiotics. FluoretiQ uses nanoprobes and sensor technology to detect bacterial presence in biological samples.
Life sciences company Bio-Techne performs research and develops products for pharmaceutical applications. It manufactures its own lines of reagents, scientific instruments and diagnostic tools, which are used by scientists and drug developers in their work. Bio-Techne publishes a catalog of molecules that can be purchased as products for use in laboratory research.
Zentraxa is a pharmaceutical and biotechnology company that specializes in producing bespoke biomaterials, such as complex novel peptides. Biomaterials are built of strings of amino acids and are used in pharmaceutical research and development for their potential as bases for biological treatment products.
Halo Therapeutics is a pharma and biotech firm that makes products for a wide range of therapeutic contexts, from oncology to dermatology. Its most notable technology product is the ENHANZE drug delivery mechanism, which uses the rHuPH20 enzyme to aid in subcutaneously injected drug absorption. This technology can be applied in many contexts, including emerging technology for auto-injection.
Amcor is an enterprise-scale packaging company that works with diverse industries to package their goods. For the pharmaceutical sector, Amcor has developed innovative solutions to the problem of how to safely and efficiently package medications. Pharmaceutical product packaging is divided by administration route, with oral, parenteral, transdermal and other routes as its four categories.
The pre-clinical stage pharmaceutical research company Imophoron makes vaccines and discovery technology for new vaccine research. Its ADDomer protein framework functions as a delivery system for vaccine candidates and is in use by the company as a development tool for research into RSV, Covid-19 and Chikungunya vaccine products.
The global life sciences company Labcorp is best known for its network of retail laboratory sites, where patients can get third-party medical testing performed according to their doctor’s directions. In addition to this work, Labcorp also has notable drug discovery and clinical trial operations through its biopharma lab services division.
Stablepharma Limited is a biopharmaceutical company that builds thermostable vaccines and drugs. Because the logistics processes are so demanding for vaccines that must be kept at certain temperatures, the potential for increased access to vaccination is huge in the thermostable category. The company’s goal is to fully eliminate the need for cold-chain transportation by using its StablevaX technology, which allows existing vaccines to be reformulated as shelf-stable products.
